Article Information
History
- February 21, 2021.
Article Versions
- Version 1 (January 4, 2021 - 05:06).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Frederic Grabowski1,
- Grzegorz Preibisch2,
- Stanisław Giziński3,
- Marek Kochańczyk1,* and
- Tomasz Lipniacki1,*
- 1Institute of Fundamental Technological Research, Polish Academy of Sciences, 02-106 Warsaw, Poland
- 2Inter-Faculty Individual Studies in Mathematics and Natural Sciences, The MISMaP College, University of Warsaw, 02-097 Warsaw, Poland
- 3Faculty of Mathematics, Informatics and Mechanics, University of Warsaw, 02-097 Warsaw, Poland
- ↵*Corresponding authors’ e-mails: mkochan{at}ippt.pan.pl, tlipnia{at}ippt.pan.pl
Posted February 21, 2021.
SARS-CoV-2 Variant of Concern 202012/01 has about twofold replicative advantage and acquires concerning mutations
